Predicting chemoresponsiveness in epithelial ovarian cancer patients using circulating small extracellular vesicle-derived plasma gelsolin

BACKGROUND: Resistance to chemotherapy continues to be a challenge when treating epithelial ovarian cancer (EOC), contributing to low patient survival rates. While CA125, the conventional EOC biomarker, has been useful in monitoring patients’ response to therapy, there are no biomarkers used to pred...

Descripción completa

Detalles Bibliográficos
Autores principales: Gerber, Emma, Asare-Werehene, Meshach, Reunov, Arkadiy, Burger, Dylan, Le, Tien, Carmona, Euridice, Mes-Masson, Anne-Marie, Tsang, Benjamin K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841140/
https://www.ncbi.nlm.nih.gov/pubmed/36642715
http://dx.doi.org/10.1186/s13048-022-01086-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841140/
https://www.ncbi.nlm.nih.gov/pubmed/36642715
http://dx.doi.org/10.1186/s13048-022-01086-x

Ejemplares similares